This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Jul 1;139(1):1-3.

doi: 10.1097/ALN.0000000000004587.

Sugammadex Is Not a Silver Bullet: Caveats Regarding Unmonitored Reversal

Michael M Todd¹, Aaron F Kopman²

Affiliations

Affiliations

¹ Department of Anesthesiology, University of Minnesota School of Medicine, Minneapolis, Minnesota.
² Retired from the Department of Anesthesiology, Weill Cornell Medical College, New York, New York.

PMID: 37279102
DOI: 10.1097/ALN.0000000000004587

Editorial

Sugammadex Is Not a Silver Bullet: Caveats Regarding Unmonitored Reversal

Michael M Todd et al. Anesthesiology. 2023.

. 2023 Jul 1;139(1):1-3.

doi: 10.1097/ALN.0000000000004587.

Authors

Michael M Todd¹, Aaron F Kopman²

Affiliations

¹ Department of Anesthesiology, University of Minnesota School of Medicine, Minneapolis, Minnesota.
² Retired from the Department of Anesthesiology, Weill Cornell Medical College, New York, New York.

PMID: 37279102
DOI: 10.1097/ALN.0000000000004587

No abstract available

PubMed Disclaimer

Comment on

A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis.
Bowdle TA, Haththotuwegama KJ, Jelacic S, Nguyen ST, Togashi K, Michaelsen KE. Bowdle TA, et al. Anesthesiology. 2023 Jul 1;139(1):6-15. doi: 10.1097/ALN.0000000000004578. Anesthesiology. 2023. PMID: 37027807 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources